Number of items: 3.
Azurmendi, L; Lapierre-Fetaud, V; Schneider, J; Montaner, J; Katan, Mira; Sanchez, Jean-Charles (2017). Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: a pilot study. Clinical Proteomics, 14:27.
Senn, R; Elkind, M S V; Montaner, J; Christ-Crain, M; Katan, M (2014). Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage. Cerebrovascular Diseases, 38(6):395-409.
Opravil, M; Sasadeusz, J; Cooper, D A; Rockstroh, J K; Clumeck, N; Clotet, B; Montaner, J; Torriani, F J; Depamphilis, J; Dieterich, D T (2008). Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection. JAIDS Journal of Acquired Immune Deficiency Syndromes, 47(1):36-49.
This list was generated on Wed Apr 25 21:55:51 2018 CEST.